JASON SNYDER: Open Payments
NPI 1790352185 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 52 payments from 9 companies in 2025. Trend: 2023 $711 · 2024 $992 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 15 | $180 |
| ABBVIE INC. | 13 | $173 |
| PFIZER INC. | 10 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $120 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Boston Scientific Corporation | 2 | $37 |
| Radius Health, Inc. | 2 | $29 |
| Globus Medical, Inc. | 1 | $29 |
| SPR Therapeutics, Inc | 1 | $26 |
Products named: Belbuca, NURTEC ODT, RELISTOR, QULIPTA, Symbravo, BOTOX, XTAMPZA, UBRELVY.
Industry payments across UT — which companies pay providers there.
